The Role of Epigenetics in the Progression of Non-Alcoholic Fatty Liver Disease

被引:6
|
作者
Edith Aguilar-Olivos, Nancy [1 ]
Oria-Hernandez, Jesus [2 ]
Ponciano-Rodriguez, Guadalupe [3 ]
Carlos Chavez-Tapia, Norberto [4 ]
Uribe, Misael [4 ]
Mendez-Sanchez, Nahum [1 ]
机构
[1] Medica Sur Clin & Fdn, Liver Res Unit, Mexico City 14050, DF, Mexico
[2] Minist Hlth, Natl Inst Pediat, Biochem & Genet Lab, Mexico City, DF, Mexico
[3] Univ Nacl Autonoma Mexico, Fac Med, Dept Publ Hlth, Mexico City 04510, DF, Mexico
[4] Medica Sur Clin & Fdn, Obes & Digest Dis Unit, Mexico City 14050, DF, Mexico
关键词
Biological markers; disease progression; DNA methylation; histones; liver; microRNAs; one-carbon metabolism; NICOTINAMIDE-N-METHYLTRANSFERASE; ATP-CITRATE LYASE; INSULIN-RESISTANCE; HEPATIC STEATOSIS; SIRT1; STEATOHEPATITIS; METABOLISM; MICE; METHYLATION; MICRORNAS;
D O I
10.2174/1389557515666150709115702
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Non-alcoholic fatty liver disease encompasses a spectrum of pathologies ranging from simple steatosis to non-alcoholic steatohepatitis. Patients with non-alcoholic steatohepatitis have increased risk of cirrhosis, liver failure and hepatocellular carcinoma. About 25% of subjects with simple steatosis progress to steatohepatitis; nowadays, the detailed pathological factors influencing the progression of non-alcoholic fatty liver disease remains unclear. It is proposed that genetic and environmental factors interact to determine the disease phenotype. Epigenetics could explain some relationships between genes and external influences. The epigenetic changes that have been related to non-alcoholic fatty liver disease are DNA methylation, one-carbon metabolism, histone modifications and the presence of micro-RNA. DNA methylation and micro-RNAs have been investigated in human samples, whereas histone modifications have only been studied until now in animal and cellular models. The aim of this study is to review the most relevant information about epigenetic changes in non-alcoholic steatohepatitis.
引用
收藏
页码:1187 / 1194
页数:8
相关论文
共 50 条
  • [31] The role of the circadian clock in the development, progression, and treatment of non-alcoholic fatty liver disease
    de Assis, Leonardo Vinicius Monteiro
    Demir, Muenevver
    Oster, Henrik
    ACTA PHYSIOLOGICA, 2023, 237 (03)
  • [32] The role of high fat diet in the progression of non-alcoholic fatty liver disease.
    Carmiel-Haggai, M
    Cederbaum, AI
    Nieto, N
    HEPATOLOGY, 2002, 36 (04) : 724A - 724A
  • [33] Carnitine signature in liver corretales with non-alcoholic fatty liver disease progression
    Jimenez Franco, Andrea
    Castane, Helena
    Baiges Gaya, Gerard
    Rodriguez-Tomas, Elisabet
    Camps Andreu, Jordi
    Joven Maried, Jorge
    JOURNAL OF HEPATOLOGY, 2022, 77 : S681 - S681
  • [34] Non-alcoholic Fatty Liver Disease
    Tan, Hui-Hui
    Chang, Jason Pik-Eu
    PROCEEDINGS OF SINGAPORE HEALTHCARE, 2010, 19 (01) : 36 - 50
  • [35] Non-alcoholic fatty liver disease
    Angulo, P
    Lindor, KD
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2002, 17 : S186 - S190
  • [36] Non-alcoholic fatty liver disease
    Powell, Elizabeth E.
    Wong, Vincent Wai-Sun
    Rinella, Mary
    LANCET, 2021, 397 (10290): : 2212 - 2224
  • [37] Non-alcoholic fatty liver disease
    Maurice, James
    Manousou, Pinelopi
    CLINICAL MEDICINE, 2018, 18 (03) : 245 - 250
  • [38] Non-alcoholic fatty liver disease
    Neuschwander-Tetri, Brent A.
    BMC MEDICINE, 2017, 15
  • [39] Non-alcoholic fatty liver disease
    Smith, Briohny W.
    Adams, Leon A.
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2011, 48 (03) : 97 - 113
  • [40] Non-alcoholic fatty liver disease
    Carreras, MP
    Tortajada, GC
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2005, 97 (05) : 377 - 377